Investor Webinar

Summary by AI BETAClose X

Clean Power Hydrogen PLC announced an investor webinar scheduled for February 26, 2026, at 6:00 p.m. GMT, hosted by its joint broker Turner Pope Investments. The webinar will feature Chief Commercial Officer Richard Scott discussing the company's Membrane-Free Electrolyser technology and its ability to provide a lower-cost solution for high-purity hydrogen and medical-grade oxygen production. The presentation will highlight CPH2's capacity to serve real-world markets with current demand, producing two valuable commodities from a single modular unit, and will touch upon the upcoming delivery of its first 1MW machine and the growing sectors it can support.

Disclaimer*

Clean Power Hydrogen PLC
19 February 2026
 

 

19 February 2026

Clean Power Hydrogen plc

("CPH2" or the "Company")

 

Investor Webinar 26 February 2026

 

CPH2 (AIM:CPH2), which has developed market disrupting and IP-protected Membrane-Free Electrolyser ("MFE") technology for the production of commercial high purity hydrogen and medical-grade oxygen, announces that Richard Scott (Chief Commercial Officer) will be presenting an Investor Webinar at 6:00p.m. (GMT) on 26 February 2026. The webinar is open to shareholders and other interested parties and is hosted by the Company's joint broker, Turner Pope Investments.

 

There will be a Q&A session for investors after the Company's presentation, for which questions can be submitted pre-event as part of the registration process.

 

To register for the webinar please us the link below:

https://www.turnerpope.com/register-cph2/

 

The webinar will focus on how CPH2 is able to support existing users of high purity hydrogen and medical grade oxygen with a proven and patented lower cost solution than competitors. Unlike other operators, CPH2 is serving real-world markets with current demand and can produce two high value commodities from one modular on-site unit. With delivery of the first 1MW machine in sight, Richard will discuss the many growing sectors the Company can now support.

 

ENDS

Enquiries:

 

Clean Power Hydrogen plc                                                                           via Square 1

Jon Duffy, Chief Executive Officer        

James Hobson, Chief Financial Officer

 

Cavendish Capital Markets Limited - NOMAD & Broker           

Neil McDonald                                                                                         +44 131 220 9771

Peter Lynch                                                                                             +44 131 220 9772

 

Turner Pope Investments (TPI) Limited - Broker

Andy Thacker/Guy McDougall                                                                +44 203 657 3657

 

Square1 Consulting Limited - Investor Relations                               +44 7831 381201

David Bick                                                                                           

 

Background on CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation and proving of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest Levelised Cost of Hydrogen ("LCOH") in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LSE: CPH2.

 

For more information: https://www.cph2.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings